Mechanisms of glucocorticoid action and insensitivity in airways disease
- Publication Type:
- Journal Article
- Pulmonary Pharmacology and Therapeutics, 2014, 29 (2), pp. 129 - 143
- Issue Date:
Files in This Item:
|Mechanisms of glucocorticoid action and insensitivity in airways disease.pdf||Published Version||1.95 MB|
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
© 2014 Elsevier Ltd. Glucocorticoids are the mainstay for the treatment of chronic inflammatory diseases including asthma and chronic obstructive pulmonary disease (COPD). However, it has been recognized that glucocorticoids do not work well in certain patient populations suggesting reduced sensitivity. The ultimate biologic responses to glucocorticoids are determined by not only the concentration of glucocorticoids but also the differences between individuals in glucocorticoid sensitivity, which is influenced by multiple factors. Studies are emerging to understand these mechanisms in detail, which would help in increasing glucocorticoid sensitivity in patients with chronic airways disease. This review aims to highlight both classical and emerging concepts of the anti-inflammatory mechanisms of glucocorticoids and also review some novel strategies to overcome steroid insensitivity in airways disease.
Please use this identifier to cite or link to this item: